Rh Family A Glycoprotein (RHAG) Peptid
Kurzübersicht für Rh Family A Glycoprotein (RHAG) Peptid (ABIN938285)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- FGAVLGKTSP TQMLIMTILE IVFFAHNEYL VSEIFKASDI GASMTIHAFG
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of RHAG antibody,
Alternative Names: RHAG control peptide, RHAG antibody Blocking Peptide, Anti-RHAG Blocking Peptide, Rh-Associated Glycoprotein Blocking Peptide, RH2 Blocking Peptide, RH50A Blocking Peptide, Rh50 Blocking Peptide, Rh50 GP Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- RHAG (Rh Family A Glycoprotein (RHAG))
-
Hintergrund
- The Rh blood group antigens are associated with human erythrocyte membrane proteins of approximately 30 kDa, the so-called Rh30 polypeptides. Heterogeneously glycosylated membrane proteins of 50 and 45 kDa, the Rh50 glycoproteins, are coprecipitated with the Rh30 polypeptides on immunoprecipitation with anti-Rh-specific mono- and polyclonal antibodies. The Rh antigens appear to exist as a multisubunit complex of CD47, LW, glycophorin B, and play a critical role in the Rh50 glycoprotein.
-
Molekulargewicht
- 45 kDa
Target
-